Caricamento...
Cost-effectiveness of QuantiFERON testing prior to initiation of biologic therapy in inflammatory bowel disease
BACKGROUND: Anti-TNF α drugs are known to reactivate latent tuberculosis (TB). Current guidelines recommend screening for latent TB infection (LTBI), with either tuberculin skin test (TST) or interferon gamma release assays (IGRA) such as QuantiFERON-TB Gold (QFT-G). Given the high rates of anergy t...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2013
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3889121/ https://ncbi.nlm.nih.gov/pubmed/23945184 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MIB.0b013e31829f008f |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|